From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD
Steven Fishbane, MD
Winning the CKD-aP Battle: A United Physician-Nurse Front
What You Don’t See: A Patient’s View of Living with CKD-aP
Optimizing Outcomes in Patients with FSGS: A Case-Based Approach in the New Era of Targeted Therapy
Jörg Latus, MD
Sayna Norouzi, MD
Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
Richard Lafayette, MD, FACP
Ankana Daga, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Maurizio Gallieni, MD
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
CKD-aP Treatment Tool Kit
Leonie Kraft, MD
Emilio Sanchez, MD, PhD